New Study Assesses Regulatory Frameworks on Embryo Testing for Genetic Conditions
Due to advancements in medical technology, embryos can be genetically screened before being implanted in the womb via in-vitro fertilization.
Due to advancements in medical technology, embryos can be genetically screened before being implanted in the womb via in-vitro fertilization.
Improved accuracy in identifying bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis will enable better targeted treatment for women.
Hologic’s first-in-category assay, cleared through FDA’s De Novo review process, provides laboratories with a highly sensitive and specific molecular diagnostic method to identify M. genitalium infections and enable effective treatment.
This month’s issue features QA/QC systems and tools from such companies as Bio-Rad Laboratories, LGC Maine Standards, and Randox Laboratories.
Read MoreValidate PCT for Abbott Architect analyzers enables laboratories to document procalcitonin linearity and calibration verification.
Read MoreAnti-Müllerian hormone testing offers a measure of a woman’s ovarian reserve.
Read MoreTo find out more about Quest’s new survey on sexually transmitted infections, CLP recently spoke with Damian P. Alagia III, MD, FACOG, FACS, medical director for women’s health at Quest Diagnostics.
Read MoreThis month’s issue features high-throughput labs systems from such companies as BD, Hologic, Roche, and TwistDx.
Read MoreAva has added a new feature to its fertility-tracking Ava bracelet, helping provide users with key insights into their ovulation during a monthly cycle.
Read MoreThorne, New York, has introduced five point-of-care health tests for fertility, heavy metals, sleep, stress, and thyroid that measure an individual’s unique biomarkers.
Read MoreLaboratories in the United States are now able to perform reproductive testing using the automated anti-Müllerian hormone assay with the company’s Access 2 or DxI immunoassay systems.
Read MoreTo find out more about FDA’s recent safety alert and its effects on the clinical laboratory community, CLP recently spoke with Ramani Wonderling, PhD, associate director for scientific relations in diagnostics at Abbott.
Read MoreIn a recent clinical trial conducted in collaboration with the University Hospital of Zurich, the Ava bracelet captured physiological changes known to occur in early pregnancy.
Read MoreThe company’s service will offer discreet panels to assess hormone biomarkers in saliva specimens, relieving laboratorians from the complexities inherent in biomarker testing in research settings.
Read MoreBBI Solutions has announced the launch of new antibodies, including inflammatory, fertility, and infectious disease markers.
Read MoreA study of 3.4 million drug monitoring lab results shows wide evidence of dangerous drug combinations, including opioids/benzodiazepines and heroin/fentanyl.
Read MoreMore than 21,300 laboratory medicine professionals and healthcare leaders registered for the 2017 AACC meeting.
Read MoreThis month’s issue features immunoassay analyzers from such companies as Arlington Scientific and Dynex Technologies.
Read More